New + Emerging Treatments

The New + Emerging Treatments conference is hosted by the Leukemia Research Foundation for leukemia patients, survivors, caregivers, family members, and healthcare professionals. Each hour-long webinar is dedicated to a specific subtype of leukemia, discussing the latest treatments and what's on the horizon, followed by a live Q + A. Participants can register for one or multiple sessions.

parameswaran-venugopal-200x250

Chronic lymphocytic leukemia (CLL)

Presented Wednesday, October 12, 2022

Parameswaran Venugopal, MD, from Rush University Medical Center covered the latest CLL treatments from the past year and discussed what new treatments are on the horizon. The presentation is followed by a live Q + A moderated by Justin Kline, MD, from University of Chicago Medicine.

ehab-atallah-200x200

Chronic myeloid leukemia (CML)

Presented Wednesday, October 12, 2022

Ehab Atallah, MD, from Medical College of Wisconsin covered the latest CML treatments from the past year and discussed what new treatments are on the horizon. The presentation is followed by a live Q + A moderated by Justin Kline, MD, from University of Chicago Medicine.

jen-mcneer-200x250

Childhood acute lymphocytic leukemia (ALL)

Presented Wednesday, October 26, 2022

Jen McNeer, MD, MS, from University of Chicago Medicine covered the latest childhood ALL treatments from the past year and discussed what new treatments are on the horizon. The presentation was followed by a live Q + A moderated by Justin Kline, MD, from University of Chicago Medicine.

emily-curran-200x250

Adult acute lymphocytic leukemia (ALL)

Presented Wednesday, October 26, 2022

Emily Curran, MD, from University of Cincinnati covered the latest adult ALL treatments from the past year and discussed what new treatments are on the horizon. The presentation was followed by a live Q + A moderated by Justin Kline, MD, from University of Chicago Medicine.

eytan-stein-200x250

Acute myeloid leukemia (AML)

Wednesday, November 9, 2022  |  7-8pm CT (5-6 PT, 6-7 MT, 8-9 ET)

Eytan Stein, MD, from Memorial Sloan Kettering Cancer Center covered the latest AML treatments from the past year and discussed what new treatments are on the horizon. The presentation was followed by a live Q + A moderated by Justin Kline, MD, from University of Chicago Medicine.

Program supporters